JNCI Journal of the National Cancer Institute最新文献

筛选
英文 中文
Re: Association of immunoglobulin E levels with glioma risk and survival. 免疫球蛋白E水平与胶质瘤风险和生存的关系。
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-03-01 DOI: 10.1093/jnci/djae344
George A Alexiou, Panagiota Zagorianakou, Spyridon Voulgaris
{"title":"Re: Association of immunoglobulin E levels with glioma risk and survival.","authors":"George A Alexiou, Panagiota Zagorianakou, Spyridon Voulgaris","doi":"10.1093/jnci/djae344","DOIUrl":"10.1093/jnci/djae344","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":"567"},"PeriodicalIF":9.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142949156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Liu and Zhang. 对刘和张的回应。
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-03-01 DOI: 10.1093/jnci/djae325
Rong Xu
{"title":"Response to Liu and Zhang.","authors":"Rong Xu","doi":"10.1093/jnci/djae325","DOIUrl":"10.1093/jnci/djae325","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":"564"},"PeriodicalIF":9.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142806398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data. RE:GLP-1受体激动剂和胰腺癌风险:使用真实世界数据的靶试验模拟。
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-03-01 DOI: 10.1093/jnci/djae324
Xiaoxia Liu, Chongjie Zhang
{"title":"RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.","authors":"Xiaoxia Liu, Chongjie Zhang","doi":"10.1093/jnci/djae324","DOIUrl":"10.1093/jnci/djae324","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":"562-563"},"PeriodicalIF":9.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RE: Characteristics of a cost-effective blood test for colorectal cancer screening. 一种具有成本效益的结肠直肠癌筛查血液检测的特点。
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-03-01 DOI: 10.1093/jnci/djae340
Qiang Hu, Xiyin Yang, Yuanshui Sun
{"title":"RE: Characteristics of a cost-effective blood test for colorectal cancer screening.","authors":"Qiang Hu, Xiyin Yang, Yuanshui Sun","doi":"10.1093/jnci/djae340","DOIUrl":"10.1093/jnci/djae340","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":"570-571"},"PeriodicalIF":9.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142882017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gerotherapeutics: aging mechanism-based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities. 老年治疗:基于衰老机制的药物和行为干预,减少癌症的种族和民族差异。
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-03-01 DOI: 10.1093/jnci/djae211
Jeanne S Mandelblatt, Michael H Antoni, Traci N Bethea, Steve Cole, Barry I Hudson, Frank J Penedo, Amelie G Ramirez, G William Rebeck, Swarnavo Sarkar, Ann G Schwartz, Erica K Sloan, Yun-Ling Zheng, Judith E Carroll, Mina S Sedrak
{"title":"Gerotherapeutics: aging mechanism-based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities.","authors":"Jeanne S Mandelblatt, Michael H Antoni, Traci N Bethea, Steve Cole, Barry I Hudson, Frank J Penedo, Amelie G Ramirez, G William Rebeck, Swarnavo Sarkar, Ann G Schwartz, Erica K Sloan, Yun-Ling Zheng, Judith E Carroll, Mina S Sedrak","doi":"10.1093/jnci/djae211","DOIUrl":"10.1093/jnci/djae211","url":null,"abstract":"<p><p>The central premise of this article is that a portion of the established relationships between social determinants of health and racial and ethnic disparities in cancer morbidity and mortality is mediated through differences in rates of biological aging processes. We further posit that using knowledge about aging could enable discovery and testing of new mechanism-based pharmaceutical and behavioral interventions (\"gerotherapeutics\") to differentially improve the health of cancer survivors from minority populations and reduce cancer disparities. These hypotheses are based on evidence that lifelong differences in adverse social determinants of health contribute to disparities in rates of biological aging (\"social determinants of aging\"), with individuals from minoritized groups experiencing accelerated aging (ie, a steeper slope or trajectory of biological aging over time relative to chronological age) more often than individuals from nonminoritized groups. Acceleration of biological aging can increase the risk, age of onset, aggressiveness, and stage of many adult cancers. There are also documented negative feedback loops whereby the cellular damage caused by cancer and its therapies act as drivers of additional biological aging. Together, these dynamic intersectional forces can contribute to differences in cancer outcomes between survivors from minoritized vs nonminoritized populations. We highlight key targetable biological aging mechanisms with potential applications to reducing cancer disparities and discuss methodological considerations for preclinical and clinical testing of the impact of gerotherapeutics on cancer outcomes in minoritized populations. Ultimately, the promise of reducing cancer disparities will require broad societal policy changes that address the structural causes of accelerated biological aging and ensure equitable access to all new cancer control paradigms.</p>","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":"406-422"},"PeriodicalIF":9.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142086043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RE: Maximizing scarce colonoscopy resources: the crucial role of stool-based tests.
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-02-28 DOI: 10.1093/jnci/djaf041
Jane A McElroy, Kevin D Everett
{"title":"RE: Maximizing scarce colonoscopy resources: the crucial role of stool-based tests.","authors":"Jane A McElroy, Kevin D Everett","doi":"10.1093/jnci/djaf041","DOIUrl":"https://doi.org/10.1093/jnci/djaf041","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":9.9,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143556860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to McElroy and Everett.
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-02-28 DOI: 10.1093/jnci/djaf042
Gloria Coronado, Carolyn Rutter
{"title":"Response to McElroy and Everett.","authors":"Gloria Coronado, Carolyn Rutter","doi":"10.1093/jnci/djaf042","DOIUrl":"https://doi.org/10.1093/jnci/djaf042","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":9.9,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143556868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Timing of depression in relation to risk of ovarian cancer.
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-02-25 DOI: 10.1093/jnci/djaf043
Steven Lehrer
{"title":"Re: Timing of depression in relation to risk of ovarian cancer.","authors":"Steven Lehrer","doi":"10.1093/jnci/djaf043","DOIUrl":"https://doi.org/10.1093/jnci/djaf043","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":9.9,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143556862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Lehrer.
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-02-25 DOI: 10.1093/jnci/djaf044
Andrea L Roberts, Laura D Kubzansky, Shelley S Tworoger
{"title":"Response to Lehrer.","authors":"Andrea L Roberts, Laura D Kubzansky, Shelley S Tworoger","doi":"10.1093/jnci/djaf044","DOIUrl":"https://doi.org/10.1093/jnci/djaf044","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":9.9,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143556867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the road to new drugs in clinical oncology: benefit of phase 2 trials.
IF 9.9 1区 医学
JNCI Journal of the National Cancer Institute Pub Date : 2025-02-25 DOI: 10.1093/jnci/djaf023
Howard S Hochster
{"title":"On the road to new drugs in clinical oncology: benefit of phase 2 trials.","authors":"Howard S Hochster","doi":"10.1093/jnci/djaf023","DOIUrl":"https://doi.org/10.1093/jnci/djaf023","url":null,"abstract":"","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":9.9,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143492183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信